Pharmaceutical PV DIV - FSB
Ended Awarded
- Contract number
- SPE2DX26FFQRS
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $24,612
Award facts
- Contract value 100% obligated
- $24,612.45 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $24,612.45 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This firm fixed-price delivery order, issued on October 27, 2025, with an ultimate completion date of October 30, 2025, represents a continuation of the agency's pharmaceutical supply chain operations supporting Department of Defense healthcare facilities. The award carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group Inc. maintains a robust portfolio of pharmaceutical products and medical consumables, including branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and emergency medical supplies.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.999 billion acquisition strategy designed to support recurring medical supply needs of military healthcare facilities worldwide. The parent IDC, awarded in November 2025, provides a 30-month base period with three 30-month option periods and positions DMS Pharmaceutical Group as a critical regional prime vendor contractor through December 31, 2036. The contractor's consistent performance on numerous recent delivery orders and its comprehensive pharmaceutical distribution capabilities align with the Defense Logistics Agency's objective to maintain a reliable, efficient supply chain for military medical operations globally.
Quick answers
Who was awarded contract SPE2DX26FFQRS?
SPE2DX26FFQRS was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on October 27, 2025.
How much is contract SPE2DX26FFQRS worth?
The government has obligated $24,612 on SPE2DX26FFQRS.
Is contract SPE2DX26FFQRS an order under another contract?
Yes. SPE2DX26FFQRS is a delivery order under SPE2DX17D9419, an indefinite delivery contract.
Was contract SPE2DX26FFQRS competed?
The extent of competition for SPE2DX26FFQRS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award